Free Cash Flow for Amgen (AMGN)
Free Cash Flow for Amgen (AMGN): headline value $8.10B · YoY -22.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
AMGN
Currently viewingFree Cash FlowSwitch metric
Latest period
$8.10B
YoY change
-22.1%
5Y CAGR
-3.9%
Peak year (2018)
$10.56B
Latest annual
$8.10B
Free Cash Flow history chart for Amgen (AMGN) from 1988 to 2025
Free Cash Flow history table for Amgen (AMGN) from 1988 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $8.10B | -22.1% | ||
| 2024 | $10.39B | +41.2% | ||
| 2023 | $7.36B | -16.2% | ||
| 2022 | $8.79B | +4.8% | ||
| 2021 | $8.38B | -15.2% | ||
| 2020 | $9.89B | +15.9% | ||
| 2019 | $8.53B | -19.2% | ||
| 2018 | $10.56B | +0.4% | ||
| 2017 | $10.51B | +10.5% | ||
| 2016 | $9.52B | +12.9% | ||
| 2015 | $8.43B | +11.6% | ||
| 2014 | $7.55B | +34.9% | ||
| 2013 | $5.60B | +7.8% | ||
| 2012 | $5.19B | +14.1% | ||
| 2011 | $4.55B | -12.6% | ||
| 2010 | $5.21B | -10.3% | ||
| 2009 | $5.81B | +9.2% | ||
| 2008 | $5.32B | +28.6% | ||
| 2007 | $4.13B | -0.9% | ||
| 2006 | $4.17B | +3.1% | ||
| 2005 | $4.04B | +71.3% | ||
| 2004 | $2.36B | +6.8% | ||
| 2003 | $2.21B | +39.0% | ||
| 2002 | $1.59B | +53.1% | ||
| 2001 | $1.04B | -13.2% | ||
| 2000 | $1.20B | +55.2% | ||
| 1999 | $771.10M | +21.7% | ||
| 1998 | $633.70M | +23.0% | ||
| 1997 | $515.10M | -7.3% | ||
| 1996 | $555.70M | -9.0% | ||
| 1995 | $610.50M | +52.2% | ||
| 1994 | $401.10M | +79.8% | ||
| 1993 | $223.10M | +205.6% | ||
| 1992 | $73.00M | -28.7% | ||
| 1991 | $102.40M | -299.2% | ||
| 1990 | -$51.40M | +102.4% | ||
| 1989 | -$25.40M | -48.3% | ||
| 1988 | -$49.10M | — |
Free Cash Flow values are taken from Amgen's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Amgen (AMGN) free cash flow totalled $8.10B – declined 22.1% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Amgen free cash flow compounded at -3.9% per year, with a net decline across the window.
Between 2018 and 2025, Amgen free cash flow declined 23.3%, falling from $10.56B to $8.10B.
Across the available history, free cash flow reached its high of $10.56B in 2018 and its low of -$51.40M in 1990.
Within Healthcare, Amgen (AMGN) ranks 8th among 8 peers we track. The peer median for free cash flow is $14.22B.
Amgen Free Cash Flow by Year
Amgen Free Cash Flow 2025: $8.10B
Amgen free cash flow in 2025 was $8.10B, declined 22.1% below 2024.
Amgen Free Cash Flow 2024: $10.39B
Amgen free cash flow in 2024 was $10.39B, surged 41.2% from 2023.
Amgen Free Cash Flow 2023: $7.36B
Amgen free cash flow in 2023 was $7.36B, declined 16.2% below 2022.
Amgen Free Cash Flow 2022: $8.79B
Amgen free cash flow in 2022 was $8.79B, edged up 4.8% from 2021.
Amgen Free Cash Flow 2021: $8.38B
Amgen free cash flow in 2021 was $8.38B.
See more financial history for Amgen (AMGN).
Sector peers — Free Cash Flow
Companies in the same sector as Amgen, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| AbbVie Inc. (ABBV) | $17.82B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| AstraZeneca PLC (AZN) | $11.77B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $6.29B | Healthcare |
Frequently asked questions
What is Amgen's free cash flow?
Latest reported free cash flow for Amgen (AMGN) is $8.10B (period ending December 31, 2025).
How has Amgen free cash flow changed year-over-year?
Amgen (AMGN) free cash flow changed -22.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Amgen free cash flow?
Amgen (AMGN) free cash flow compound annual growth rate is -3.9% over the most recent 5 years available.
When did Amgen free cash flow hit its highest annual value?
Amgen free cash flow reached its highest annual value of $10.56B in 2018.
What was Amgen free cash flow in 2024?
Amgen (AMGN) free cash flow in 2024 was $10.39B.
What was Amgen free cash flow in 2025?
Amgen (AMGN) free cash flow in 2025 was $8.10B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
AMGN Overview
Company profile, financial tools, and key metrics
AMGN Revenue Counter
Earns $1,166 every second. See per minute, hour, and day.
AMGN Earnings Counter
Earns $244.51 per second net profit. See per minute, hour, and day.
AMGN Economic Scale
Exceeds El Salvador's GDP. Compare with world economies.
AMGN What If Invested
What if you had invested $1,000? See historical returns from any date.
AMGN How It Makes Money
Discover visual breakdown of $36.77B in revenue — where it comes from and where it goes.
AMGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AMGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AMGN Daily Price Character
Balanced · 48.1% historical win rate (green days). Streaks & record days.
AMGN Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
AMGN Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
AMGN Dividend Profile
Yield: 2.86%. Safety: 8/8. See full history.
AMGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AMGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.